{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:07:54Z","timestamp":1770509274598,"version":"3.49.0"},"reference-count":90,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The primary systemic vasculitides represent a spectrum of rare but life-threatening conditions that may also affect the eye in various forms. This article reviews recently published data on ocular manifestations of systemic vasculitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Early diagnosis and timely treatment has led to better visual outcomes in giant cell arteritis (GCA). Gene expression from orbital tissues could distinguish granulomatosis with polyangiitis (GPA) from sarcoidosis and Graves disease, but not from idiopathic orbital inflammation. Rituximab was an effective therapeutic option in ocular GPA. An ocular attack severity scoring system, flare levels, fluorescein angiography and optical coherence tomography parameters have been suggested as predictors of visual prognosis in Beh\u00e7et disease. Efficacy of tumor necrosis factor-alpha inhibitors, interferon \u03b1 and anti-interleukin-1 agents was shown in noncontrolled studies of ocular Beh\u00e7et disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Widely used fast-track pathway care as well as ocular imaging to detect subclinical involvement may enable earlier diagnosis of GCA and prevention of permanent visual loss. Orbital inflammation may not remain idiopathic with advances in gene expression profiling of orbital tissues. With an increased availability and the use of biologic agents, visual prognosis will improve in patients with severe ocular complications of systemic vasculitides.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000345","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T17:42:10Z","timestamp":1474479730000},"page":"24-32","source":"Crossref","is-referenced-by-count":14,"title":["Systemic vasculitis and the eye"],"prefix":"10.1097","volume":"29","author":[{"given":"Ilknur","family":"Tugal-Tutkun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.rdc.2010.05.005","article-title":"Ocular manifestations of ANCA-associated vasculitis","volume":"36","author":"Kubal","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5582\/irdr.2016.01014","article-title":"Granulomatosis with polyangiitis (Wegener's disease): an updated review of ocular disease manifestations","volume":"5","author":"Kubaisi","year":"2016","journal-title":"Intractable Rare Dis Res"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-015-8518-3","article-title":"Ocular Involvement in systemic autoimmune diseases","volume":"49","author":"Generali","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"403042","DOI":"10.1155\/2014\/403042","article-title":"Gender and ocular manifestations of connective tissue diseases and systemic vasculitides","volume":"2014","author":"Choudhary","year":"2014","journal-title":"J Ophthalmol"},{"key":"R5-20230829","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-207532","article-title":"Unilateral proptosis in a woman with asthma","volume":"2015","author":"Sakaue","year":"2015","journal-title":"BMJ Case Rep"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/09273948.2014.883547","article-title":"Microscopic polyangiitis manifesting as lymphoma","volume":"23","author":"Huang","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12348-014-0033-9","article-title":"The role of conjunctival biopsy in the diagnosis of granulomatosis with polyangiitis","volume":"5","author":"Ursea","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"(1 Suppl 75)","key":"R8-20230829","first-page":"S96","article-title":"Ocular involvement in giant cell arteritis","volume":"31","author":"Figus","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/BOR.0000000000000271","article-title":"Retinal vasculitis","volume":"28","author":"Rosenbaum","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3928\/23258160-20160419-11","article-title":"Ultra wide-field \u0131ndocyanine green angiogram highlights choroidal perfusion delay secondary to giant cell arteritis","volume":"47","author":"Tang","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/bjophthalmol-2014-304900","article-title":"Spectral domain optical coherence tomography findings in eyes with acute ischaemic retinal whitening","volume":"99","author":"Coady","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10792-013-9822-7","article-title":"Optical coherence tomography imaging in uveitis","volume":"34","author":"Onal","year":"2014","journal-title":"Int Ophthalmol"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10792-015-0153-8","article-title":"Anterior segment spectral domain optical coherence tomography imaging of patients with anterior scleritis","volume":"36","author":"Levison","year":"2016","journal-title":"Int Ophthalmol"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jamaophthalmol.2015.0668","article-title":"A Promising future for optical coherence tomography angiography","volume":"133","author":"Nagiel","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4103\/2008-322X.180709","article-title":"Optical coherence tomography angiography in retinal diseases","volume":"11","author":"Chalam","year":"2016","journal-title":"J Ophthalmic Vis Res"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3899\/jrheum.121473","article-title":"Vasculitis Clinical Research Consortium. New features of disease after diagnosis in 6 forms of systemic vasculitis","volume":"40","author":"Grayson","year":"2013","journal-title":"J Rheumatol"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","article-title":"Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature","volume":"42","author":"Rothschild","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"945262","DOI":"10.1155\/2015\/945262","article-title":"Behcet's disease: is there geographical variation? A review far from the Silk Road","volume":"2015","author":"Leonardo","year":"2015","journal-title":"Int J Rheumatol"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/WNO.0000000000000116","article-title":"Third nerve palsy as the initial manifestation of giant cell arteritis","volume":"34","author":"Thurtell","year":"2014","journal-title":"J Neuroophthalmol"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00296-014-3126-8","article-title":"Multiple cranial nerve palsies in giant cell arteritis and response to cyclophosphamide: a case report and review of the literature","volume":"35","author":"Fytili","year":"2015","journal-title":"Rheumatol Int"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1756-185X.2012.01746.x","article-title":"An unusual cause of visual loss in a patient with giant cell arteritis","volume":"16","author":"Shakir","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/bjo.87.4.510","article-title":"Tonic pupils from giant cell arteritis","volume":"87","author":"Foroozan","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/09273948.2013.849351","article-title":"Giant cell arteritis presenting with uveitis","volume":"22","author":"Slemp","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/eye.2014.181","article-title":"Transient visual loss due to reversible \u2019pending\u2019 central retinal artery occlusion in occult giant cell arteritis","volume":"28","author":"Sane","year":"2014","journal-title":"Eye (Lond)"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaophthalmol.2015.1967","article-title":"Cotton-wool spots associated with mild nonprogressive visual loss","volume":"133","author":"Thanos","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"228","DOI":"10.11604\/pamj.2014.19.228.3132","article-title":"Unilateral multifocal choroidal ischemia revealing a giant cell arteritis: a case report","volume":"19","author":"Hafidi","year":"2014","journal-title":"Pan Afr Med J"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/eye.2010.169","article-title":"Giant cell arteritis presenting as macular choroidal ischaemia","volume":"25","author":"Olali","year":"2011","journal-title":"Eye (Lond)"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/rheumatology\/keu329","article-title":"Large-vessel giant cell arteritis: a cohort study","volume":"54","author":"Muratore","year":"2015","journal-title":"Rheumatology"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3899\/jrheum.140188","article-title":"Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort","volume":"42","author":"Singh","year":"2015","journal-title":"J Rheumatol"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ophtha.2016.05.008","article-title":"Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis","volume":"123","author":"Chen","year":"2016","journal-title":"Ophthalmology"},{"issue":"(2 Suppl 89)","key":"R31-20230829","first-page":"S103","article-title":"Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study","volume":"33","author":"Patil","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/rheumatology\/kev289","article-title":"The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?","volume":"55","author":"Diamantopoulos","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/eye.2015.85","article-title":"Ocular pulse amplitude as a diagnostic adjunct in giant cell arteritis","volume":"29","author":"Knecht","year":"2015","journal-title":"Eye (Lond)"},{"key":"R34-20230829","first-page":"17","article-title":"Preserved visual acuity in anterior ischemic optic neuropathy secondary to giant cell (temporal) arteritis","volume":"8","author":"Antonio-Santos","year":"2016","journal-title":"J Vasc Interv Neurol"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/WNO.0000000000000269","article-title":"Giant cell arteritis presenting as unilateral anterior ischemic optic neuropathy associated with bilateral optic nerve sheath enhancement on magnetic resonance imaging","volume":"35","author":"Liu","year":"2015","journal-title":"J Neuroophthalmol"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2015.12.015","article-title":"Management of giant cell arteritis: recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)","volume":"37","author":"Bienvenu","year":"2016","journal-title":"Rev Med Interne"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/BOR.0000000000000265","article-title":"Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis","volume":"28","author":"Koster","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0000000000000292","article-title":"Varicella zoster virus triggers the immunopathology of giant cell arteritis","volume":"28","author":"Gilden","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10792-011-9500-6","article-title":"Takayasu's retinopathy","volume":"31","author":"Elizalde","year":"2011","journal-title":"Int Ophthalmol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/09273948.2012.690491","article-title":"Blindness in a pulseless young woman: lessons learned","volume":"20","author":"Sakthiswary","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/ICB.0000000000000091","article-title":"Headache and whiteout vision as the presenting symptoms in a case of Takayasu retinopathy","volume":"8","author":"Lee","year":"2014","journal-title":"Retin Cases Brief Rep"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/IAE.0b013e3181fe540b","article-title":"Ocular manifestations of Takayasu arteritis: a cross-sectional study","volume":"31","author":"Peter","year":"2011","journal-title":"Retina"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcjo.2013.09.014","article-title":"Retinal angiography and colour Doppler of retrobulbar vessels in Takayasu arteritis","volume":"49","author":"Matos","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/ICB.0000000000000073","article-title":"Thickened retinal ganglion cell complex in patient with severe Takayasu retinopathy at early stage","volume":"9","author":"Matsumoto-Otake","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"R45-20230829","first-page":"2013","article-title":"\u2019Eye is a window to the pulse\u2019: bilateral ocular ischaemic syndrome as a presenting manifestation of Takayasu arteritis","author":"Shailaja","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/0301-4738.60090","article-title":"A case of unusual presentation of Takayasu's arteritis","volume":"58","author":"Das","year":"2010","journal-title":"Indian J Ophthalmol"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0301-4738.182945","article-title":"Nodular scleritis as a presenting feature of Takayasu's arteritis","volume":"64","author":"Shukla","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"R48-20230829","article-title":"Clinical features and treatment outcomes of orbital inflammatory disease in Singapore: a 10-year clinicopathologic review","author":"Young","year":"2016","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ophtha.2013.12.003","article-title":"Clinical and imaging features predictive of orbital granulomatosis with polyangiitis and the risk of systemic involvement","volume":"121","author":"Tan","year":"2014","journal-title":"Ophthalmology"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ophtha.2015.06.026","article-title":"Clinical and imaging features of lacrimal gland involvement in granulomatosis with polyangiitis","volume":"122","author":"Tan","year":"2015","journal-title":"Ophthalmology"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.ophtha.2015.04.016","article-title":"Tissue interleukin-17 and interleukin-23 as biomarkers for orbital granulomatosis with polyangiitis","volume":"122","author":"Isa","year":"2015","journal-title":"Ophthalmology"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.yexmp.2015.01.009","article-title":"Molecular diagnosis of orbital inflammatory disease","volume":"98","author":"Rosenbaum","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yexmp.2015.07.002","article-title":"Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling","volume":"99","author":"Rosenbaum","year":"2015","journal-title":"Exp Mol Pathol"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/bjophthalmol-2015-307460","article-title":"Scleritis in patients with granulomatosis with polyangiitis (Wegener)","volume":"100","author":"Cocho","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s00417-014-2696-1","article-title":"Five-year outcome in immune-mediated scleritis","volume":"252","author":"Bernauer","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ophtha.2015.01.016","article-title":"Long-term outcomes of rituximab therapy in ocular granulomatosis with polyangiitis: impact on localized and nonlocalized disease","volume":"122","author":"Joshi","year":"2015","journal-title":"Ophthalmology"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12016-014-8425-z","article-title":"Ocular involvement of Beh\u00e7et's syndrome: a comprehensive review","volume":"49","author":"Ozyazgan","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"R58-20230829","article-title":"HLA-B51 carriers are susceptible to ocular symptoms of Beh\u00e7et disease and the association between the two becomes stronger towards the east along the Silk Road: a literature survey","author":"Horie","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/1756-185X.12691","article-title":"Adult Behcet's disease in Iran: analysis of 6075 patients","volume":"19","author":"Davatchi","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2014.10.013","article-title":"Uveitis in Beh\u00e7et disease in a tertiary center over 25 years: the KKESH Uveitis Survey Study Group","volume":"159","author":"Arevalo","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/09273948.2014.918154","article-title":"Changes in ocular manifestations of Beh\u00e7et disease in Korean patients over time: a single-center experience in the 1990\u200as and 2000\u200as","volume":"23","author":"Chung","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"R62-20230829","article-title":"Ocular Beh\u00e7et's disease: changing patterns over time, complications and long-term visual prognosis","author":"Accorinti","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R63-20230829","article-title":"Beh\u00e7et's disease ocular attack score 24 and visual outcome in patients with Beh\u00e7et's disease","author":"Tanaka","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R64-20230829","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3349\/ymj.2015.56.4.1087","article-title":"Correlation between fluorescein angiographic findings and visual acuity in Beh\u00e7et retinal vasculitis","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med J"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/IAE.0000000000000197","article-title":"Use of ultra-wide-field retinal imaging in the management of active Beh\u00e7et retinal vasculitis","volume":"34","author":"Mesquida","year":"2014","journal-title":"Retina"},{"key":"R66-20230829","article-title":"Inter-observer variability in scoring ultra-wide-field fluorescein angiography in patients with Beh\u00e7et retinal vasculitis","author":"Moon","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R67-20230829","article-title":"The importance of quantitative measurement methods for uveitis: laser flare photometry endorsed in Europe while neglected in Japan where the technology measuring quantitatively intraocular inflammation was developed","author":"Herbort","year":"2016","journal-title":"Int Ophthalmol"},{"key":"R68-20230829","article-title":"Evaluation of intraocular inflammation with laser flare photometry in Beh\u00e7et uveitis","author":"Yalcindag","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R69-20230829","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00417-008-0823-6","article-title":"Use of laser flare-cell photometry to quantify intraocular inflammation in patients with Beh\u00e7et uveitis","volume":"246","author":"Tugal-Tutkun","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5935\/0004-2749.20140056","article-title":"Inner and outer segment junction (IS\/OS line) integrity in ocular Beh\u00e7et's disease","volume":"77","author":"Y\u00fcksel","year":"2014","journal-title":"Arq Bras Oftalmol"},{"key":"R71-20230829","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ajo.2014.11.029","article-title":"Nonglaucomatous localized retinal nerve fiber layer defects in Beh\u00e7et uveitis","volume":"159","author":"Oray","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R72-20230829","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1136\/bjophthalmol-2014-305333","article-title":"Changes in subfoveal choroidal thickness associated with uveitis activity in patients with Beh\u00e7et's disease","volume":"98","author":"Ishikawa","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R73-20230829","doi-asserted-by":"crossref","first-page":"865394","DOI":"10.1155\/2014\/865394","article-title":"Evaluation of the macular, peripapillary nerve fiber layer and choroid thickness changes in Beh\u00e7et's disease with spectral-domain OCT","volume":"2014","author":"Ata\u015f","year":"2014","journal-title":"J Ophthalmol"},{"key":"R74-20230829","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12886-015-0162-4","article-title":"Reconstitution of disrupted photoreceptor layer in uveitis associated with Beh\u00e7et's disease by infliximab treatment","volume":"15","author":"Takeuchi","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"R75-20230829","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5301\/ejo.5000728","article-title":"Thickness changes in foveal, macular, and ganglion cell complex regions associated with Beh\u00e7et uveitis during remission","volume":"26","author":"G\u00fcrl\u00fc","year":"2016","journal-title":"Eur J Ophthalmol"},{"key":"R76-20230829","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/rheumatology\/keu266","article-title":"Anti-TNF-\u03b1 therapy in patients with refractory uveitis due to Beh\u00e7et's disease: a 1-year follow-up study of 124 patients","volume":"53","author":"Calvo-R\u00edo","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R77-20230829","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.ophtha.2014.04.042","article-title":"Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Beh\u00e7et's disease: a multicenter study","volume":"121","author":"Takeuchi","year":"2014","journal-title":"Ophthalmology"},{"issue":"(4 Suppl 84)","key":"R78-20230829","first-page":"S58","article-title":"Adalimumab for treatment of severe Beh\u00e7et's uveitis: a retrospective long-term follow-up study","volume":"32","author":"Interlandi","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R79-20230829","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of antitumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"R80-20230829","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s10384-013-0294-0","article-title":"Beh\u00e7et's disease ocular attack score 24: evaluation of ocular disease activity before and after initiation of infliximab","volume":"58","author":"Kaburaki","year":"2014","journal-title":"Jpn J Ophthalmol"},{"key":"R81-20230829","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10384-015-0404-2","article-title":"Association between the major histocompatibility complex and clinical response to infliximab therapy in patients with Beh\u00e7et uveitis","volume":"59","author":"Kuroyanagi","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"R82-20230829","article-title":"Interferon alpha-2a therapy in patients with refractory Beh\u00e7et uveitis","author":"Hasanreisoglu","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R83-20230829","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3349\/ymj.2015.56.4.1158","article-title":"Clinical experience of \u0131nterferon alfa-2a treatment for refractory uveitis in Beh\u00e7et's disease","volume":"56","author":"Park","year":"2015","journal-title":"Yonsei Med J"},{"key":"R85-20230829","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00417-014-2856-3","article-title":"Antiinterferon alpha antibodies and autoantibodies in patients with Beh\u00e7et's disease uveitis treated with recombinant human interferon alpha-2a","volume":"253","author":"Aydinoglu-Candan","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"(4 Suppl 84)","key":"R86-20230829","first-page":"S175","article-title":"Interferon alfa-associated depression in patients with Beh\u00e7et's syndrome: a prospective controlled study","volume":"32","author":"Keskin","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"R87-20230829","article-title":"Temperament and character traits in patients with Beh\u00e7et's disease with\/without eye \u0131nvolvement","author":"Ucar","year":"2015","journal-title":"Semin Ophthalmol"},{"key":"R88-20230829","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10067-015-3004-0","article-title":"Efficacy and safety profile of antiinterleukin-1 treatment in Beh\u00e7et's disease: a multicenter retrospective study","volume":"35","author":"Emmi","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R89-20230829","article-title":"Safety and efficacy of gevokizumab in patients with Beh\u00e7et's disease uveitis: results of an exploratory phase 2 study","author":"Tugal-Tutkun","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R90-20230829","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/ICU.0000000000000210","article-title":"Local (topical and intraocular) therapy for ocular Adamantiades-Beh\u00e7et's disease","volume":"26","author":"Fabiani","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"R91-20230829","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/09273948.2015.1042167","article-title":"Intravitreal dexamethasone implant for treatment of refractory Beh\u00e7et posterior uveitis: one-year follow-up results","volume":"23","author":"Co\u015fkun","year":"2015","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201701000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T06:42:20Z","timestamp":1693291340000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201701000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000345","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}